|
1
|
Groot N, de Graeff N, Avcin T,
Bader-Meunier B, Brogan P, Dolezalova P, Feldman B, Kone-Paut I,
Lahdenne P, Marks SD, et al: European evidence-based
recommendations for diagnosis and treatment of childhood-onset
systemic lupus erythematosus: The SHARE initiative. Ann Rheum Dis.
76:1788–1796. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Leal GN, Diniz MF, Brunelli J, Lianza AC,
Sallum AM and Silva CA: What are the benefits of two-dimensional
speckle tracking echocardiography for diagnosis and treatment
follow-up of childhood-onset systemic lupus erythematosus
myocarditis? Rev Assoc Med Bras (1992). 62:490–493. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tunnicliffe DJ, Singh-Grewal D, Kim S,
Craig JC and Tong A: Diagnosis, monitoring, and treatment of
systemic lupus erythematosus: A systematic review of clinical
practice guidelines. Arthritis Care Res. 67:1440–1452. 2015.
View Article : Google Scholar
|
|
4
|
Fu SM, Deshmukh US and Gaskin F:
Pathogenesis of systemic lupus erythematosus revisited 2011: End
organ resistance to damage, autoantibody initiation and
diversification and HLA-DR. J Autoimmun. 37:104–112. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kuhn A, Bonsmann G, Anders HJ, Herzer P,
Tenbrock K and Schneider M: The diagnosis and treatment of systemic
lupus erythematosus. Dtsch Arztebl Int. 112:423–432.
2015.PubMed/NCBI
|
|
6
|
Zhao J, Wang K, Wang X, Li T, Guo L, Gu L,
Chen Z, Sun F, Wang H, Li J, et al: The performance of different
anti-dsDNA autoantibodies assays in Chinese systemic lupus
erythematosus patients. Clin Rheumatol. 37:139–144. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ruzieh M, Batizy L, Dasa O, Oostra C and
Grubb B: The role of autoantibodies in the syndromes of orthostatic
intolerance: A systematic review. Scand Cardiovasc J. 51:243–247.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma WT, Chang C, Gershwin ME and Lian ZX:
Development of autoantibodies precedes clinical manifestations of
autoimmune diseases: A comprehensive review. J Autoimmun.
83:95–112. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu C, Li M, Liu J, Qian J, Xu D, Zhang S,
Li P, Zhao J, Tian X and Zeng X: Anti-SmD1 antibodies are
associated with renal disorder, seizures, and pulmonary arterial
hypertension in Chinese patients with active SLE. Sci Rep.
7:76172017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bai Y, Tong Y, Liu Y and Hu H: Self-dsDNA
in the pathogenesis of systemic lupus erythematosus. Clin Exp
Immunol. 191:1–10. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Arif Z, Neelofar K, Tarannum I, Arfat MY,
Ahmad S, Zaman A, Khan MA, Badar A, Islam SN2 and Iqubal MA: SLE
autoantibodies are well recognized by peroxynitrite-modified-HSA:
Its implications in the pathogenesis of SLE. Int J Biol Macromol.
106:1240–1249. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Agmon-Levin N, Dagan A, Peri Y, Anaya JM,
Selmi C, Tincani A, Bizzaro N, Stojanovich L, Damoiseaux J, Cohen
Tervaert JW, et al: The interaction between anti-Ro/SSA and
anti-La/SSB autoantibodies and anti-infectious antibodies in a wide
spectrum of auto-immune diseases: Another angle of the autoimmune
mosaic. Clin Exp Rheumatol. 35:929–935. 2017.PubMed/NCBI
|
|
13
|
Zhang B, Jarrell JA, Price JV, Tabakman
SM, Li Y, Gong M, Hong G, Feng J, Utz PJ and Dai H: An integrated
peptide-antigen microarray on plasmonic gold films for sensitive
human antibody profiling. PLoS One. 8:e710432013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Haddon DJ, Diep VK, Price JV, Limb C, Utz
PJ and Balboni I: Autoantigen microarrays reveal autoantibodies
associated with proliferative nephritis and active disease in
pediatric systemic lupus erythematosus. Arthritis Res Ther.
17:1622015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Price JV, Tangsombatvisit S, Xu G, Yu J,
Levy D, Baechler EC, Gozani O, Varma M, Utz PJ and Liu CL: On
silico peptide microarrays for high-resolution mapping of antibody
epitopes and diverse protein-protein interactions. Nat Med.
18:1434–1440. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Price JV, Haddon DJ, Kemmer D, Delepine G,
Mandelbaum G, Jarrell JA, Gupta R, Balboni I, Chakravarty EF,
Sokolove J, et al: Protein microarray analysis reveals BAFF-binding
autoantibodies in systemic lupus erythematosus. J Clin Invest.
123:5135–5145. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Balboni I, Niewold TB, Morgan G, Limb C,
Eloranta ML, Rönnblom L, Utz PJ and Pachman LM: Interferon-α
induction and detection of anti-ro, anti-la, anti-sm, and anti-rnp
autoantibodies by autoantigen microarray analysis in juvenile
dermatomyositis. Arthritis Rheum. 65:2424–2429. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gori A, Cretich M, Vanna R, Sola L, Gagni
P, Bruni G, Liprino M, Gramatica F, Burastero S and Chiari M:
Multiple epitope presentation and surface density control enabled
by chemoselective immobilization lead to enhanced performance in
IgE-binding fingerprinting on peptide microarrays. Anal Chim Acta.
983:189–197. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
De Plano LM, Carnazza S, Messina GML,
Rizzo MG, Marletta G and Guglielmino SPP: Specific and selective
probes for Staphylococcus aureus from phage-displayed random
peptide libraries. Colloids Surf B Biointerfaces. 157:473–480.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kafi MA, Cho HY and Choi JW: Engineered
peptide-based nanobiomaterials for electrochemical cell chip. Nano
Converg. 3:172016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Maksimov P, Zerweck J, Maksimov A, Hotop
A, Gross U, Spekker K, Däubener W, Werdermann S, Niederstrasser O,
Petri E, et al: Analysis of clonal type-specific antibody reactions
in Toxoplasma gondii seropositive humans from Germany by
peptide-microarray. PLoS One. 7:e342122012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhong L, Coe SP, Stromberg AJ, Khattar NH,
Jett JR and Hirschowitz EA: Profiling tumor-associated antibodies
for early detection of non-small cell lung cancer. J Thorac Oncol.
1:513–519. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Woodard KM and Chapman CJ: Lung cancer-can
autoantibodies provide an aid to diagnosis? Expert Opin Med Diagn.
2:911–923. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chapman CJ, Murray A, McElveen JE, Sahin
U, Luxemburger U, Türeci O, Wiewrodt R, Barnes AC and Robertson JF:
Autoantibodies in lung cancer: Possibilities for early detection
and subsequent cure. Thorax. 63:228–233. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Saleh J, Brunner C, Gölzer R, Nastainczyk
W and Montenarh M: p53 autoantibodies from patients with head and
neck cancer recognise common epitopes on the polypeptide chain of
p53. Cancer Lett. 233:48–56. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Saleh J, Kreissler-Haag D and Montenarh M:
p53 autoantibodies from patients with colorectal cancer recognize
common epitopes in the N- or C-terminus of p53. Int J Oncol.
25:1149–1155. 2004.PubMed/NCBI
|
|
27
|
de Jesus GR, Mendoza-Pinto C, de Jesus NR,
Dos Santos FC, Klumb EM, Carrasco MG and Levy RA: Understanding and
managing pregnancy in patients with lupus. Autoimmune Dis.
2015:9434902015.PubMed/NCBI
|
|
28
|
Marder W, Ganser MA, Romero V, Hyzy MA,
Gordon C, McCune WJ and Somers EC: In utero azathioprine exposure
and increased utilization of special educational services in
children born to mothers with systemic lupus erythematosus.
Arthritis Care Res. 65:759–766. 2013. View Article : Google Scholar
|
|
29
|
Crampton SP, Morawski PA and Bolland S:
Linking susceptibility genes and pathogenesis mechanisms using
mouse models of systemic lupus erythematosus. Dis Model Mech.
7:1033–1046. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gottschalk TA, Tsantikos E and Hibbs ML:
Pathogenic inflammation and its therapeutic targeting in systemic
lupus erythematosus. Front Immunol. 6:5502015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ramos-Casals M, Sanz I, Bosch X, Stone JH
and Khamashta MA: B-cell-depleting therapy in systemic lupus
erythematosus. Am J Med. 125:327–336. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ching KH, Burbelo PD, Tipton C, Wei C,
Petri M, Sanz I and Iadarola MJ: Two major autoantibody clusters in
systemic lupus erythematosus. PLoS One. 7:e320012012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhu H, Luo H, Yan M, Zuo X and Li QZ:
Autoantigen microarray for high-throughput autoantibody profiling
in systemic lupus erythematosus. Genomics Proteomics
Bioinformatics. 13:210–218. 2015. View Article : Google Scholar : PubMed/NCBI
|
